Related Experiment Video
Updated: Apr 17, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Moving targets: Emerging roles for MMPs in cancer progression and metastasis
Gemma Shay1, Conor C Lynch1, Barbara Fingleton2
1Dept. of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Abstract:
Matrix metalloproteinases have long been associated with cancer. Clinical trials of small molecule inhibitors for this family of enzymes however, were spectacularly unsuccessful in a variety of tumor types. Here, we discuss some of the newer roles that have been uncovered for MMPs in cancer that would not have been targeted with those initial inhibitors or in the patient populations analyzed. We also consider novel ways of using cancer-associated MMP activity for clinical benefit.
Insights
Matrix metalloproteinases (MMPs) were unsuccessfully targeted in cancer trials. Newer MMP roles in cancer and novel therapeutic strategies offer potential clinical benefits beyond initial inhibitor approaches.
Area of Science:
- Oncology
- Biochemistry
- Enzymology
Background:
- Matrix metalloproteinases (MMPs) are implicated in cancer progression.
- Previous clinical trials using small molecule MMP inhibitors failed across various cancer types.
Purpose of the Study:
- To explore novel roles of MMPs in cancer beyond those targeted by early inhibitors.
- To identify new clinical applications for targeting MMP activity in cancer patients.
Main Methods:
- Review of recent scientific literature on MMPs in cancer.
- Analysis of emerging MMP functions and their relevance to tumor biology.
- Exploration of innovative therapeutic strategies targeting MMPs.
Main Results:
- Identified new cancer-associated functions of MMPs not addressed by prior inhibitor studies.
- Highlighted patient populations and tumor types where MMPs may play distinct roles.
- Proposed novel approaches for leveraging MMP activity for therapeutic benefit.
Conclusions:
- The failure of early MMP inhibitors does not negate their potential in cancer therapy.
- Understanding novel MMP roles is crucial for developing effective cancer treatments.
- New strategies targeting MMPs could offer clinical benefits for cancer patients.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The Tumor Microenvironment
Cancer Cell Migration through Invadopodia

